NewsRx

Search our medical news database

Finance

Torrent Pharmaceuticals reports 23% consolidated growth in formulation sales

Published in Biotech Business Week, November 29th, 2004

The Ahmedabad based Torrent Pharmaceuticals Limited posted a 23% consolidated growth in formulation sales for quarter ended September 30, 2004.

The company has reported a 15% increase in Profit after Tax (PAT) to $47.4 million as compared to $41 million in the previous year for Q2. Net sales for the quarter has boosted by 12% to $282.6 million.

In its meeting dated October 30, 2004, the board approved issue of Foreign Currency Convertible Bonds (FCCB) or Equity (through GDR/ADR) of $50 million with a green shoe option of 15%. Given the issue's demand, higher sales are expected in the market.

The company has also finalized credit...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook